Combination ACE inhibitor and angiotensin II receptor antagonist therapy in diabetic nephropathy

Lee A. Hebert,Michael E. Falkenhain,N. Stanley Nahman,Fernando G Cosio,Thomas M. O’Dorisio

Combination ACE inhibitor and angiotensin II receptor antagonist therapy in diabetic nephropathy

1999

Lee A. Hebert
Michael E. Falkenhain
N. Stanley Nahman
Fernando G Cosio
Thomas M. O’Dorisio

The benefit of angiotensin-converting enzyme (ACE) inhibitor (i) therapy in diabetic glomerulosclerosis is thought to be largely the result of attenuation of angiotensin II (AngII) effects on blood pr

Keywords:

Angiotensin II
Angiotensin II receptor antagonist
Nephropathy
Diabetic nephropathy
Angiotensin-converting enzyme
Diabetes mellitus
Endocrinology
Angiotensin II receptor type 1
Medicine
ACE inhibitor
Internal medicine
Losartan
Renin–angiotensin system

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

104

Citations